Day: 8. December 2020

China’s photovoltaic power generation reaches 18.7 GW, highest in the world

According to the Secretary General of the China Photovoltaic Industry Association, polycrystalline silicon production increased 18.9% year-on-year to about 290,000 tons, and module production increased 6.7% to 80GW. Newly installed capacity of photovoltaic power generation nationwide increased by 17% to 18.7 GW, and the amount of photovoltaic power generation increased by 16.9% to 2005 billion […]

Shanghai claims R&D investments of 4% of its GDP in 2019

According to the Shanghai Technology Innovation Center Construction Report 2019, Shanghai’s overall R&D spending as a percentage of GDP was 4% last year, above the national average of 2.23%. There were more than 5,961 newly certified high-tech companies, with over 12,000 high-tech companies, and a total of 2155 science and technology giant companies (science and […]

Qingdao completes test run of new-generation monorail

The straddle-type monorail, developed by CRRC Qingdao Sifang,  achieves a maximum speed of 100 km/h. Width of the car body is 3 meters, and the train achieves passage over high gradiens, small turnings, accommodates a large number of passengers, and emits low noise. Equipped for driverless operation to GoA4, the new-generation trainset uses a permanent magnet traction package, […]

Hebei Medical University First Hospital is the first ward in China completely covered by 5G

The Hebei Medical University First Hospital General Ward in Shijiazhuang City, Hebei Province, has approximately 1,100 beds, 66 private ICU rooms, and 21 operating rooms that have been digitized and equipped with a behavioral management system. The latest 5G digital equipment has been installed in the ward, and three major 5G networks comprise the hospital, […]

Anhui Zhifei started phase-III trial of China’s first recombinant COVID-19 vaccine

Chinese vaccine maker Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. has started phase-3 clinical trials for its COVID-19 vaccine, planning to recruit 29,000 volunteers across the world. This is China’s first phase-3 efficacy study for a recombinant subunit COVID-19 vaccine candidate. It was Jointly developed by the company and the CAS Institute of Microbiology, Randomized, double-blind […]

Scroll to top